150 related articles for article (PubMed ID: 16780019)
1. Assessing invasion criteria in fine needle aspirates from breast carcinoma diagnosed as DICS or invasive carcinoma: can we identify an invasive component in addition to DCIS?
Sauer T; Garred O; Lømo J; Naess O
Acta Cytol; 2006; 50(3):263-70. PubMed ID: 16780019
[TBL] [Abstract][Full Text] [Related]
2. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
[TBL] [Abstract][Full Text] [Related]
3. Are epithelial cells in fat or connective tissue a reliable indicator of tumor invasion in fine-needle aspiration of the breast?
Maygarden SJ; Brock MS; Novotny DB
Diagn Cytopathol; 1997 Feb; 16(2):137-42. PubMed ID: 9067105
[TBL] [Abstract][Full Text] [Related]
4. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
5. Fine needle aspiration cytology of breast ductal carcinoma in situ.
Venegas R; Rutgers JL; Cameron BL; Vargas H; Butler JA
Acta Cytol; 1994; 38(2):136-43. PubMed ID: 8147202
[TBL] [Abstract][Full Text] [Related]
6. p63 Staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast.
Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
J Clin Pathol; 2002 Dec; 55(12):936-9. PubMed ID: 12461063
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
[TBL] [Abstract][Full Text] [Related]
8. Fine-needle aspiration cytology of the breast: Invasive vs. in situ carcinoma.
McKee GT; Tambouret RH; Finkelstein D
Diagn Cytopathol; 2001 Jul; 25(1):73-7. PubMed ID: 11466818
[TBL] [Abstract][Full Text] [Related]
9. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
[TBL] [Abstract][Full Text] [Related]
10. Comparative features of ductal carcinoma in situ and infiltrating ductal carcinoma of the breast on fine-needle aspiration biopsy.
Wang HH; Ducatman BS; Eick D
Am J Clin Pathol; 1989 Dec; 92(6):736-40. PubMed ID: 2556017
[TBL] [Abstract][Full Text] [Related]
11. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
12. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
Yu KD; Wu LM; Liu GY; Wu J; Di GH; Shen ZZ; Shao ZM
Ann Surg Oncol; 2011 May; 18(5):1342-8. PubMed ID: 21042943
[TBL] [Abstract][Full Text] [Related]
13. The cytopathology of ductal carcinoma in situ of the breast. A detailed analysis of fine needle aspiration cytology of 58 cases compared with 101 invasive ductal carcinomas.
Bonzanini M; Gilioli E; Brancato B; Cristofori A; Bricolo D; Natale N; Valentini A; Dalla Palma P
Cytopathology; 2001 Apr; 12(2):107-19. PubMed ID: 11284955
[TBL] [Abstract][Full Text] [Related]
14. Cytologic features of ductal carcinoma in situ in fine-needle aspiration of the breast mirror the histopathologic growth pattern heterogeneity and grading.
Sauer T; Lømo J; Garred O; Naess O
Cancer; 2005 Feb; 105(1):21-7. PubMed ID: 15593325
[TBL] [Abstract][Full Text] [Related]
15. Intraductal carcinoma (ductal carcinoma in situ) of the breast. A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma.
Moriya T; Silverberg SG
Cancer; 1994 Dec; 74(11):2972-8. PubMed ID: 7954261
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
17. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
19. Is ductal carcinoma in situ with "possible invasion" more predictive of invasive carcinoma than pure ductal carcinoma in situ?
Arazi-Kleinman T; Causer PA; Nofech-Mozes S; Jong RA
Can Assoc Radiol J; 2012 May; 63(2):146-52. PubMed ID: 21561735
[TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma-in-situ of the breast: fine-needle aspiration cytology of 12 cases.
Sneige N; White VA; Katz RL; Troncoso P; Libshitz HI; Hortobagyi GN
Diagn Cytopathol; 1989; 5(4):371-7. PubMed ID: 2558863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
